Navigation Links
Immunotec Inc. announces appointment of President & CEO James A. Northrop

VAUDREUIL-DORION, QC, Oct. 11 /PRNewswire-FirstCall/ - The Board of Directors of Immunotec Inc. is very pleased to announce the appointment of Mr. James A. Northrop as President and Chief Executive Officer, effective November 5, 2007.

A member of the Board of Directors of Immunotec Inc., Mr. Northrop is a seasoned chief executive with a record of success in rapid growth situations, Mr. Northrop has impressive experience in the direct selling, consumer packaged goods, cosmetics, fashion and retail industries. He is well-known for his ability to see the essence of a business and position it for future growth. Mr. Northrop has acted as Chairman, Chief Executive Officer and President for a number of companies, including 11 years as the Chairman/CEO of Princess House, a direct sales company where his leadership significantly impacted profitability through development of the Hispanic market, expansion of the product line and establishment of a strong trust relationship with its more than 15,000 independent field representatives.

Recognizing the impressive foundation laid by his predecessor, Mr. Northrop will implement his proven strategy of building on the existing culture of an organization, while adding the functional expertise needed to fuel sales and promote network growth. A former Chairman of the U.S. Direct Selling Association Board of Directors, Mr. Northrop has extensive connections within the direct selling industry and a deep-seated understanding and appreciation for this powerful business model.

Immunotec's Board of Directors has approved the granting of 700,000 stock options to Mr. Northrop under Immunotec's stock option plan, at a price of $0.66 per share. The closing price of Immunotec shares was $0.66 per share on October 10, 2007.

About Immunotec

Immunotec operates out of a 37,000 square foot facility located in Vaudreuil-Dorion, Quebec, Canada as well as a distribution centre located in Swanton, Vermont, USA. Immunotec is engaged primarily in the development and marketing of dietary supplements, food, vitamins, personal care products and natural health products, many of which are manufactured on its behalf by third parties. Immunotec's products are distributed and sold in Canada and the United States through a network marketing system and in other countries under exclusive distributorship agreements.

Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):